[ad_1]
Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 6.35% on an annualized basis producing an average annual return of 14.14%. Currently, Vertex Pharmaceuticals has a market capitalization of $76.69 billion.
Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 20 years ago, it would be worth $13,361.93 today based on a price of $299.04 for VRTX at the time of writing.
Vertex Pharmaceuticals’s Performance Over Last 20 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.